Between October 18–21, this website will move to a new web address (from health.gov to odphp.health.gov). During that time, some functions might not work as expected. We appreciate your patience and understanding as we’re working to make this transition as smooth as possible.

U.S. Department of Health and Human Services Office of Disease Prevention and Health Promotion

US Medical Eligibility Criteria (US MEC) for Contraceptive Use, 2016

About this resource:

HHS Non-systematic review

Source: Centers for Disease Control and Prevention

Last Reviewed: July 2016

Workgroups: Family Planning Workgroup

This report includes recommendations on specific contraceptive methods for people with certain characteristics or medical conditions. The recommendations are meant to help health care providers counsel women, men, and couples about choosing a type of birth control. Updates in the report include guidance for:

  • Women with cystic fibrosis 
  • Women with multiple sclerosis
  • Women using certain psychotropic drugs or St. John’s wort

In addition, there were revisions to recommendations for emergency contraception and revisions recommendations for women with a variety of diseases and conditions.

Read more about this resource

Objectives related to this resource (2)

Increase the proportion of women at risk for unintended pregnancy who use effective birth control — FP‑10
Little or no detectable change
Increase the proportion of adolescent females at risk for unintended pregnancy who use effective birth control — FP‑11
Little or no detectable change

Suggested Citation

1.

Division of Reproductive Health, National Center for Chronic Disease Prevention and Health Promotion. (2016). US Medical Eligibility Criteria (US MEC) for Contraceptive Use, 2016. Retrieved from https://www.cdc.gov/reproductivehealth/contraception/mmwr/mec/summary.html